These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2953387)

  • 1. An ultrastructural and histochemical study of the prominent inflammatory response in D(+)-galactosamine hepatotoxicity.
    MacDonald JR; Beckstead JH; Smuckler EA
    Br J Exp Pathol; 1987 Apr; 68(2):189-99. PubMed ID: 2953387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of ubiquinone-10 on the development of D-galactosamine-induced hepatitis in rats].
    Sugrobova NP; Medvednik RS; Efimova LV; Katarzhnova TV; Liubarev AE; Shaposhnikov VM; Obol'nikova EA; Poznanskaia AA
    Biull Eksp Biol Med; 1992 Nov; 114(11):504-6. PubMed ID: 1290824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and experimental histochemical studies on the activities of liver lysosomal enzymes and gamma-glutamyl transpeptidase (gamma-GTP) (author's transl)].
    Sato R
    Hokkaido Igaku Zasshi; 1978 Jul; 53(4):287-303. PubMed ID: 32125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The action of silymarin on Galactosamine-induced hepatitis in the rat (author's transl)].
    Barbarino F; Suciu A; Cotutiu C; Ban A
    Wien Klin Wochenschr; 1977 Feb; 89(3):90-5. PubMed ID: 189515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopathology of acute galactosamine hepatitis in rats.
    Jonker AM; Dijkhuis FW; Kroese FG; Hardonk MJ; Grond J
    Hepatology; 1990 Apr; 11(4):622-7. PubMed ID: 2328956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Liver tissue enzymes in rats with galactosamine hepatitis during simultaneous administration of choline-orotate].
    Petzold H
    Cesk Gynekol; 1973 Jul; 27(5):290-3. PubMed ID: 4269483
    [No Abstract]   [Full Text] [Related]  

  • 7. Oval cell proliferation and the origin of small hepatocytes in liver injury induced by D-galactosamine.
    Lemire JM; Shiojiri N; Fausto N
    Am J Pathol; 1991 Sep; 139(3):535-52. PubMed ID: 1716045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-galactosamine-induced liver injury in immunosuppressed mice.
    Schaff Z; Lapis K; Szendröi M
    Acta Morphol Hung; 1984; 32(1):67-72. PubMed ID: 6087623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of preliminary fasting on the development of D-galactosamine-induced acute lesion of the liver in rats].
    Adzharov D; Donchev N; Kerimova M; Naĭdenova E; Borov B
    Biull Eksp Biol Med; 1989 Jan; 107(1):33-6. PubMed ID: 2914170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Morphological characteristics of D-galactosamine hepatitis].
    Popov A; Klouchek-Popova E; Stoilova M
    Eksp Med Morfol; 1983; 22(2):74-80. PubMed ID: 6667658
    [No Abstract]   [Full Text] [Related]  

  • 11. [Enzyme histochemical findings in the rat liver following galactosamine lesions and cholinorotate].
    Petzold H; Neupert A
    Z Gesamte Inn Med; 1972 Dec; 27(24):1087-90. PubMed ID: 4265973
    [No Abstract]   [Full Text] [Related]  

  • 12. Potentiation of hepatotoxicity by ethanol in galactosamine-induced hepatitis in rats: role of propylthiouracil protection.
    Nadkarni GD; Naik SB; Talavdekar RV; Soman CS; Talwalkar GV; Ganatra RD
    Acta Pharmacol Toxicol (Copenh); 1983 Feb; 52(2):90-4. PubMed ID: 6846026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pattern of D-galactosamine-induced hepatocellular injury modified by simultaneous application of D (--)-fructose.
    Rumpelt HJ; Bode C
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1981; 36(2-3):235-45. PubMed ID: 6116337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystamine modulation of galactosamine-induced hepatotoxicity.
    MacDonald JR; Gandolfi AJ; Sipes IG
    Toxicol Appl Pharmacol; 1984 May; 73(3):551-8. PubMed ID: 6719469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of disulfiram on function of the liver of rats with galactosamine-induced hepatitis.
    Mach T
    Pol J Pharmacol Pharm; 1986; 38(3):235-41. PubMed ID: 3095801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histochemical and immunohistochemical study on the expression of alkaline phosphatase, gamma-glutamyl transpeptidase and alpha-fetoprotein during the process of rat hepatocyte proliferation.
    Chida K
    Kitasato Arch Exp Med; 1990 Sep; 63(2-3):91-8. PubMed ID: 1710683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of syrepar in experimental liver dystrophy in albino rats].
    Skakun LN
    Farmakol Toksikol; 1976; 39(3):333-5. PubMed ID: 140815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoprotective effect of 16, 16' dimethyl prostaglandin E2 and some drugs on an acute galactosamine induced liver damage in rat.
    Stachura J; Tarnawski A; Szczudrawa J; Bogdał J; Mach T; Klimczyk B; Kirchmayer S
    Folia Histochem Cytochem (Krakow); 1980; 18(4):311-7. PubMed ID: 7203270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the pathogenesis of galactosamine hepatitis. Indications of extrahepatocellular mechanisms responsible for liver cell death.
    Liehr H; Grün M; Seelig HP; Seelig R; Reutter W; Heine WD
    Virchows Arch B Cell Pathol; 1978 Feb; 26(4):331-44. PubMed ID: 416592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental paracetamol-induced hepatic necrosis: a light- and electron-microscope, and histochemical study.
    Dixon MF; Dixon B; Aparicio SR; Loney DP
    J Pathol; 1975 May; 116(1):17-29. PubMed ID: 1159574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.